detail-1-01

ADVANCING
FOR ONE

✓ Life Sciences
✓ Medical Devices and Med-tech

✓ Biotech, Pharma and Biopharmaceuticals
✓ Healthcare, Digital Health and Health-tech

The pandemic has brought into sharp focus the critical need for the industry, academia, governments, regulators, and other stakeholders in the ecosystem to intensify their collaboration for ensuring healthcare innovation at scale and delivery with equitable access. With this context, the 20th edition of Asia’s largest Life Sciences and Healthcare forum will feature prominent government dignitaries, industry leaders, researchers, entrepreneurs, and other delegates, and explore the theme of Advancing for ONE: Shaping the next generation of humanized healthcare.

Sessions

Schedule

DAY 1

Friday
24 Feb 2023
time-shape-top
10:30-11:30 am
Inauguration of the 20th BioAsia Convention
11:30-12:00 pm
Dr. Vas Narsimhan (CEO, Novartis)
Keynote Address: Dr. Vas Narasimhan, CEO, Novartis, Switzerland
12:00-1:30 pm
1-1-new-copy-1 (1)
Panel Discussion - Operationalizing the "One Health" approach: Nexus of science, indigenous knowledge, policy
  • Importance of cross-sectoral collaboration: what are the expectations from each part of the ecosystem (what role are they expected to play/what contribution can they make)?
  • What policy enablement would encourage 'One Health' approach?
  • How to operationalize the 'One Health' approach in India?
Plenary Talk: Dr. Richard Hatchett, CEO, CEPI, UK (10 mins)
Panelists:

Panelists:

  • Dr. Soumya Swaminathan, Chief Scientist, World Health Organization, Switzerland
  • Dr. Richard Hatchett, CEO, CEPI, UK
  • Dr. Samit Hirawat, Executive Vice President, Chief Medical Officer, Global Drug Development, Bristol Myers Squibb, USA
  • Dr. VK Paul, Member, NITI Aayog*
  • Ms. Cynthia McCaffrey, UNICEF Representative to India
  • Dr. M Srinivas, Director, All India* Institute of Medical Sciences (AIIMS)
  • Dr. Krishna M Ella, Founder and Executive Chairman, Bharat Biotech International Ltd*

Moderator: Dr. Gagandeep Kang, Virologist and Professor, Dept. of Gastrointestinal Sciences, CMC Vellore

1:30–2:30 pm
Networking Lunch & Visit to the Exhibition

2:30–3:45 pm
1-2-new-1
Panel Discussion - Healthcare for all: Successes, challenges, and what next?
  • Where are we on our journey of achieving Universal Healthcare (recognizing the success thus far, discussing future action plan)?
  • How can we strengthen the healthcare infrastructure/resources availability (personnel and physical)?
  • What role can digital/ technology and data (e.g. real world data) play in improving healthcare access and outcome?
  • How can we increase focus on preventive healthcare in India (insurance, awareness in masses, behavior/mindset of population and healthcare system, focus on nutrition for all)?
  • What new innovative and sustainable financing mechanisms can be explored?
  • Global best practices/case studies on use of digital, improving patient awareness/experience, innovative financing mechanisms, and achieving Universal Healthcare.
Panelists:
  • Mr. Lav Agarwal IAS, Joint Secretary, Ministry of Health and Family Welfare, Government of India*
  • Dr. Shyam Bishen, Head, Shaping the Future of Health and Healthcare, Member of Executive Committee, World Economic Forum
  • Mr. Annaswamy Vaidheesh, CEO, North star Asia LLP
  • Dr. Prem Pavoor, Senior Partner, Head of India & Healthcare Investments, Eight Roads Ventures
  • Prof. K. Srinath Reddy, Honorary Distinguished Professor and Goodwill Ambassador, PHFI for Public Health Partnerships

 

Moderator: Mr. Vikas Dandekar, Editor - Pharma and Life Sciences, ET Prime

3:50–5:00 pm
1-3-2
Panel Discussion - Healthcare reimagined: Telemedicine, wearables, and healthcare in the METAVERSE
  • Changes in patient’s journey/healthcare experience due to digital technology?
  • Next generation remote health care models: home healthcare, virtual clinics (healthcare anywhere, anytime)?
  • Metaverse – new possibilities and realities?
Panelists:
  • Dr. Gregory Moore, Corporate Vice President, Microsoft, USA
  • Mr. Agam Upadhyay, SVP, Chief Technology Officer, GSK, USA

Moderator: Mr. Ram Deshpande, Partner, Digital Transformation, EY

5:00–6:00 pm
Networking Break & Visit to the Exhibition
6:00–7:30 pm
1-4-1-copy-1-1-copy-2
CEO Conclave Panel Discussion
Future growth driver: What's next for India?

India continues to strengthen its foothold in the pharmaceutical industry – country’s leadership in generics was established long back, and COVID vaccines demonstrate industry’s success in rapid innovation capabilities.

What could drive the future growth for Indian pharmaceutical industry?

  • China plus one opportunity
  • Overcoming the uncertainty of global markets
  • Encouraging policy for enabling innovation and self-sustenance in KSMs and API (e.g., research linked incentives/RLI)
  • Further strengthen presence in biosimilars market
  • Contextualizing new areas (e.g. mRNA technology, CAR-T) to India and emerging markets
Panelists:

Chair: Mr. KT Rama Rao, Hon. Minister of I&C, Government of Telangana

  • Dr. Rahul Singhvi, CEO, Resilience, USA
  • Mr. Satish Reddy, Chairman, Dr. Reddy’s Laboratories
  • Mr. Ajay Piramal, Chairman, Piramal Group
  • Mr. Dilip Shanghvi, Managing Director, Sun Pharma
  • Ms. Mahima Datla, Managing Director, Biological E Ltd.
  • Mr. Glenn Saldanha, MD and CEO, Glenmark Pharmaceuticals

Moderator: Ms. Shereen Bhan, Managing Editor, CNBC-TV18

 

CEO Conclave Sponsor

Presentation of the Genome Valley Excellence Award 2023 followed by Keynote Address:
Prof. Robert S. Langer, David H. Koch Institute Professor, Massachusetts Institute of Technology, USA
8:00 pm
Networking Reception (Only for Invitees)

Business cocktail parties are a great opportunity to break out of your shell.

time-shape-bottom

DAY 2

Saturday
25 Feb 2023
time-shape-top
10:30-11:15 am
2-1-copy-1
Fireside chat

Dr. Sumbul Desai, VP Health, Apple, USA

Dr. Sangita Reddy, Joint Managing Director of Apollo Hospitals (India)

11:20-12:25 pm
2-2-new-1-copy-1
Panel Discussion - Data, analytics and technology to transform drug R&D: Redefining innovation
  • Benefits of using data analytics and technology across the R&D process, i.e. drug discovery to clinical trials (improved productivity and efficiency)
  • Potential of new technology platforms, e.g. cell & gene therapy, stem cell therapy, CRISPR, oncolytic viruses, RNAi
  • Success stories and challenges from Indian industry
  • Global best practices in R&D to develop, manufacture and supply innovative medicines
  • Importance of partnerships and collaborations
  • Opportunities for India pharma industry (including small biotechs and CRO)
Panelists:
  • Dr. S. Chandrasekhar, Secretary to the Government of India, Department of Science & Technology
  • Mr. Krishna Kanumuri, MD & CEO, Sai Life Sciences
  • Mr. Mahesh Bhalgat, COO, Syngene
  • Dr. Arun Anand, COO, Immuneel Therapeutics
  • Prof. Rahul Purwar, Associate Professor – IIT Bombay, CEO & Founder, ImmunoACT
  • Prof. Joanna T. Brougher, Owner & Principal, BioPharma Law Group, and Adjunct Professor, Cornell Law School and University of Pennsylvania*

Moderator: Dr. Narendra Chirmule, Founder-director, SymphonyTech Biologics

Session Sponsor

12:30-1:30 pm
2-3new-1
Panel Discussion - India for India and India for world: Where does quality stand?
  • What challenges we face today in India regarding drug and device quality/quality perception?
  • What have we done to increase focus on drug and devices quality and how successful have we been?
  • What more needs to be done?
  • What are the real issues and how can we address those (e.g., infrastructure and people/training/culture investments to establish right quality frameworks, and establish quality by design?)
  • Will digital transformation help?
  • What other urgent initiatives do we need to take?
Panelists:
  • Mr. Mark Abdoo, Associate Commissioner for Global Policy and Strategy, US FDA
  • Dr. Sarah McMullen, Country Director - India, FDA
  • Dr. Carmelo Rosa, Acting Director, Division of International Drug Policy, US FDA
  • Prof. Sarfaraz K. Niazi, Adj. Professor of Pharmaceutical Sciences, University of Illinois, Chicago, USA
  • Mr. Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines Ltd.
  • Mr. Pavan Kumar Mocherla, EVP & President Greater Asia, BD
  • Mr. Michael Cutter, Chief Quality Officer, Biocon Biologics Ltd.

Moderator: Ms. Ekta Batra, Anchor & Associate Editor Research, CNBC-TV18

 

1:30–2:30 pm
Networking Lunch & Visit to the Exhibition

2:30–3:45 pm
2-4-copy-1
Panel Discussion - Med-tech penetration: What is the way ahead?
  • India has been strong in frugal innovation as also evidenced by some innovative COVID diagnostics: how can India continue to build strength?
  • Digital therapeutics (e.g. sensor and AI-based diagnostics and treatment) – with the inherent IT strength, how can India make it big in this space?
  • When and how will India foray into complex and innovative medical devices?
  • What are the regulatory transformation requirements?
Panelists:
  • Mr. Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD)
  • Mr. Bhargav Kotadia, MD, Sahajanand Medical Technologies Ltd.
  • Dr. Girish Krishnamurthy, CEO TATA Medical and Diagnostics Ltd.
  • Mr. Narendra Varde, Managing Director, India and Neighbouring Markets, Roche Diagnostics*
3:50–5:00 pm
this-also-new-1
Panel Discussion - Integrated Healthcare: the future of care delivery model

Globally, all healthcare systems are moving towards Integrated healthcare to improve overall health outcomes for patient and reduce healthcare costs.

  • Tech industry will contribute to next-generation health and the new interplay of strategic partnerships, advanced technologies, and data strategies in health care.
  • Interoperability is a very important requirement for integrated healthcare systems – what is the plan to ensure this?
  • What regulatory and policy interventions will be required for the entire ecosystem to work collaboratively, while keeping patients at the center?
  • How can technology enable providing healthcare in the hinterland? Is it easier to start integrated healthcare in the hinterland?
  • How will technology enable in drug registry and create measures to tackle counterfeit drugs?
Panelists:
  • Dr. Basant Garg, Additional CEO, National Health Authority (NHA)*
  • Ms. Aashima Gupta, Global Director, Global Healthcare Solutions, Google Cloud, USA
  • Mr. Ramesh Byrapaneni, Managing Director, Endiya Partners
  • Mr. Jason Mitakidis, Founder, Cyclica and HealthWorks, Canada
  • Mr. Alok Joshi, CEO, ABCD Technologies

Moderator: Mr. Suresh Subramanian, Partner and National Life Sciences Leader, EY

5:00–5:30 pm
Networking Break & Visit to the Exhibition

5:30-7:00 pm
last-copy-new-1-1
Panel Discussion - Global Supply chain transformation
  • Where are we two years post COVID? How much did India actually benefit from China Plus One strategy?
  • What further investments are required?
  • What regulatory and government support is needed?
  • What role can technology play?
  • ESG/Sustainability enablement practices in relation to manufacturing/supply chain? Adopting ESG as a culture
Panelists:
  • Mr. Parameswaran Iyer, CEO, NITI Aayog*
  • Ms. S Aparna, Secretary to the Government of India, Department of Pharmaceuticals
  • Mr. Manni Kantipudi, CEO, Aragen Life Sciences
  • Mr. Madan R Krishnan, VP & MD, Indian Sub-Continent (South Asia), Medtronic
  • Mr. Samir Mehta, Chairman, Torrent Group*
  • Dr. Satyanarayana Chava, Founder & CEO, Laurus Labs*
7:00-8:00 pm
Startup Showcase and Valedictory Ceremony
8:00 pm
Gala Dinner (Only for Invitees)

time-shape-bottom

DAY 3

Sunday
26 Feb 2023
time-shape-top
10:30 am - 1:00 pm
Exhibition and Networking

Past Speakers

Speakers 2023

Event Forecast

BioAsia 2023 will bring together the global industry leaders, researchers, policy makers, innovators, and investors together on one platform to intensify their collaboration for ensuring healthcare innovation at scale, and delivery with equitable access.
+
Countries
+
High Profile Speakers
+
Corporates
+
Partnering Meetings
+
Participants

Gallery